D. E. Shaw & Co., Inc. Enzo Biochem Inc Transaction History

D. E. Shaw & Co., Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.61 - $4.08 $39,867 - $62,322	-15,275 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.82 - $2.61 $3,305 - $4,739	-1,816 Reduced 10.63%	15,275 $38,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.02 $95,598 - $142,924	-47,326 Reduced 73.47%	17,091 $36,000
Q2 2020 Aug 14, 2020	SELL	$2.12 - $3.22 $50,123 - $76,130	-23,643 Reduced 26.85%	64,417 $144,000
Q1 2020 May 15, 2020	SELL	$1.82 - $3.87 $109,270 - $232,350	-60,039 Reduced 40.54%	88,060 $223,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $3.68 $32,271 - $46,209	-12,557 Reduced 7.82%	148,099 $390,000
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.0 $292,391 - $388,560	-97,140 Reduced 37.68%	160,656 $578,000
Q2 2019 Aug 14, 2019	SELL	$2.79 - $4.31 $100,878 - $155,836	-36,157 Reduced 12.3%	257,796 $869,000
Q1 2019 May 15, 2019	BUY	$2.54 - $4.02 $141,193 - $223,463	55,588 Added 23.32%	293,953 $802,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $14,558 - $24,855	-5,918 Reduced 2.42%	238,365 $663,000
Q3 2018 Nov 14, 2018	BUY	$3.81 - $5.53 $35,631 - $51,716	9,352 Added 3.98%	244,283 $1.01 Million
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $20,624 - $27,635	-4,076 Reduced 1.71%	234,931 $1.22 Million
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $487,288 - $750,226	89,740 Added 60.12%	239,007 $1.31 Million
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $295,184 - $382,110	-36,219 Reduced 19.53%	149,267 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $1.94 Million - $2.12 Million	185,486	185,486 $1.94 Million

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.